3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Follicular
6
Leukemia, Lymphocytic, Chronic, B-Cell
4
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma
3
Lymphoma, Large B-Cell, Diffuse
2
Neoplasms
1
Lymphoma, T-Cell
1
Lymphoma, B-Cell
1
Interventions
pembrolizumab
29
Paclitaxel
13
Carboplatin
11
Cisplatin
10
Pemetrexed
6
lenvatinib
5
Oxaliplatin
4
Gemcitabine
4
Fluorouracil
4
Capecitabine
4
Albumin-Bound Paclitaxel
4
patritumab deruxtecan
3
olaparib
3
Leucovorin
3
Acetaminophen
3
130-nm albumin-bound paclitaxel
3
belzutifan
2
Levoleucovorin
2
Irinotecan
2
Histamine H2 Antagonists
2
Histamine Antagonists
2
Etoposide
2
Docetaxel
2
Dexamethasone
2
Cetuximab
2
Bevacizumab
2
Axitinib
2
zanidatamab
1
trifluridine tipiracil drug combination
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Bendamustine Hydrochloride
×
30 days
×
Clear all
No trials found.